Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-07-15
1990-03-20
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548335, A61K 31415, C07D23358
Patent
active
049102141
ABSTRACT:
The separated d and l enantiomers of medetomidine and their salts are selective and potent .alpha..sub.2 -receptor agonists.
REFERENCES:
patent: 4544664 (1985-10-01), Karjalainen et al.
Chemical Abstracts, 105: 183977c (1986) [JPN. Kokai 61, 134, 314, Farmos, 6/21/86].
Noller, C., Chemistry of Carbon Compounds, 2nd Ed., W. B. Saunders, Philadelphia, 1957, pp. 341-344.
Karjalainen Arto J.
Savolainen Eino J.
Virtanen Raimo E.
Farmos Yhtyma Oy
Schwartz Richard A.
LandOfFree
Optical isomer of an imidazole derivative medetomidine as an alp does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Optical isomer of an imidazole derivative medetomidine as an alp, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Optical isomer of an imidazole derivative medetomidine as an alp will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-793151